Evidence map›Paper›PMID 24135572›Full record

ArticleVaccine2014

Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections.

Rebecca M Brotman, Jacques Ravel, Patrik M Bavoil, Patti E Gravitt, Khalil G Ghanem

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 104 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Observational
  6. Review
  7. Article
  8. Article
  9. How does geographical diversity shape vaccine efficacy?Clinical and experimental vaccine research · 2024
    Review
  10. Describing the Reproductive Microbiome ofAnimals : an open access journal from MDPI · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Microbiota in health and diseases.Signal transduction and targeted therapy · 2022
    Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rebecca M BrotmanInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: rbrotman@som.umaryland.edu.
Jacques RavelInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: jravel@som.umaryland.edu.
Patrik M BavoilDepartment of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, MD, USA. Electronic address: PBavoil@umaryland.edu.
Patti E GravittDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: pgravitt@jhsph.edu.
Khalil G GhanemDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: kghanem@jhmi.edu.
University of Maryland, Baltimore · USJohns Hopkins University · US

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Serologic Biomarkers of Human Sexually Transmitted Infection and DiseaseU19AI084044 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI KO, DENNIS CHUN-YONE · 2009 to 2018
$22.8M
Duration of Hormonal Contraceptive Use: Immune Responses & Vaginal MicrobiotaR01AI089878 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GHANEM, KHALIL G · 2011 to 2015
$3.4M
Molecular Epidemiology of the Vaginal MicrobiomeK01AI080974 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BROTMAN, REBECCA M. · 2010 to 2014
$644k
NCATS NIH HHS UL1 TR001079NIAID NIH HHS K01 AI080974NIAID NIH HHS K01-AI080974NIAID NIH HHS R01 AI089878NIAID NIH HHS R01-AI089878NIAID NIH HHS U19 AI084044NIAID NIH HHS U19-AI084044
6 · The paper itself

Abstract

The female and male reproductive tracts are complex eco-systems where immune cells, hormones, and microorganisms interact. The characteristics of the reproductive tract mucosa are distinct from other mucosal sites. Reproductive tract mucosal immune responses are compartmentalized, unique, and affected by resident bacterial communities and sex hormones. The female and male genital microbiomes are complex environments that fluctuate in response to external and host-associated stimuli. The female vaginal microbiota play an important role in preventing colonization by pathogenic organisms. Sex hormones and their duration of exposure affect the composition and stability of the microbiome as well as systemic and mucosal immune responses. In addition to the characteristics of the pathogen they are targeting, successful vaccines against sexually transmitted pathogens must take into account the differences between the systemic and mucosal immune responses, the compartmentalization of the mucosal immune responses, the unique characteristics of the reproductive tract mucosa, the role of the mucosal bacterial communities, the impact of sex hormones, and the interactions among all of these factors.

Indexed as

Immunity, MucosalMicrobiotaVaccinesAdaptive ImmunityFemaleGenitalia, MaleGonadal Steroid HormonesHumansImmunity, InnateMaleSexually Transmitted DiseasesVaginaGonadal Steroid HormonesVaccinesMucosal immunologyReviewSex hormonesSexually transmitted infectionsVaccinesVaginal microbiota

Identifiers

PMID24135572
PMCPMC3964794
OpenAlexW2092116660

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.